MDxHealth SA
MDXH
$2.19
-$0.018-0.82%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 45.51% | 65.02% | 89.43% | 96.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 45.51% | 65.02% | 89.43% | 96.02% |
| Cost of Revenue | -- | 29.27% | 36.45% | 47.26% | 67.74% |
| Gross Profit | -- | 57.29% | 88.42% | 128.57% | 127.44% |
| SG&A Expenses | -- | 12.32% | 22.14% | 34.59% | 53.02% |
| Depreciation & Amortization | -- | 20.48% | 109.32% | 183.53% | -- |
| Other Operating Expenses | -- | -125.07% | -134.13% | 558.57% | 752.03% |
| Total Operating Expenses | -- | 17.47% | 23.67% | 35.74% | 52.66% |
| Operating Income | -- | 27.99% | 29.28% | 21.45% | -18.96% |
| Income Before Tax | -- | 15.48% | 15.97% | 2.15% | -52.73% |
| Income Tax Expenses | -- | 200.00% | -- | -- | -- |
| Earnings from Continuing Operations | -- | 15.48% | 15.97% | 2.14% | -52.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | 15.48% | 15.97% | 2.14% | -52.73% |
| EBIT | -- | 27.99% | 29.28% | 21.45% | -18.96% |
| EBITDA | -- | 39.25% | 42.06% | 34.41% | -13.92% |
| EPS Basic | -- | 40.46% | 47.19% | 38.70% | -23.18% |
| Normalized Basic EPS | -- | 78.91% | 78.82% | 78.82% | -0.57% |
| EPS Diluted | -- | 40.46% | 47.19% | 38.70% | -23.18% |
| Normalized Diluted EPS | -- | 78.91% | 78.82% | 78.82% | -0.57% |
| Average Basic Shares Outstanding | -- | 35.16% | 56.16% | 61.37% | 25.44% |
| Average Diluted Shares Outstanding | -- | 35.16% | 56.16% | 61.37% | 25.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |